FERNANDES CONRAD J 4
4 · Teledyne LeCroy, Inc. · Filed Aug 7, 2012
Insider Transaction Report
Form 4
FERNANDES CONRAD J
Vice President
Transactions
- Disposition to Issuer
Common Stock
2012-08-03$14.30/sh−5,332$76,248→ 0 total - Disposition to Issuer
Stock Appreciation Right
2012-08-03−62,250→ 0 totalExercise: $4.07→ Common Stock (62,250 underlying) - Disposition to Issuer
Stock Appreciation Right
2012-08-03−50,000→ 0 totalExercise: $8.82→ Common Stock (50,000 underlying) - Disposition to Issuer
Stock Appreciation Right
2012-08-03−18,000→ 0 totalExercise: $7.60→ Common Stock (18,000 underlying) - Disposition to Issuer
Stock Appreciation Right
2012-08-03−121,000→ 0 totalExercise: $8.06→ Common Stock (121,000 underlying)
Footnotes (13)
- [F1]Disposed of for a cash payment pursuant to the agreement and plan of merger by and among LeCroy Corporation, Teledyne Technologies Incorporated, and Luna Merger Sub, Inc. (the "Merger Agreement").
- [F10]The SARs, of which 41,500 were vested and 20,750 were unvested, were converted in the Merger Agreement into the right to receive a cash payment equal to $10.23 per share (representing the difference between the base price of the SAR and the merger consideration of $14.30).
- [F11]12,500 SARs were exercisable on 8/17/12, 12,500 SARS were exercisable on 8/17/13, 12,500 SARs were exercisable on 8/17/14, and 12,500 SARs were exercisable on 8/17/15.
- [F12]12,500 SARs expire on 8/17/16, 12,500 SARS expire on 8/17/17, 12,500 SARs expire on 8/17/18, and 12,500 SARs expire on 8/17/19.
- [F13]The SARs, which were unvested, were converted in the Merger Agreement into the right to receive a cash payment equal to $5.48 per share (representing the difference between the base price of the SAR and the merger consideration of $14.30).
- [F2]3,000 SARs were exercisable on 8/21/10 and 15,000 SARs were exercisable on 8/21/11.
- [F3]3,000 SARs expire on 8/21/14 and 15,000 SARs expire on 8/21/15.
- [F4]The SARs, which were vested, were converted in the Merger Agreement into the right to receive a cash payment equal to $6.70 per share (representing the difference between the base price of the SAR and the merger consideration of $14.30).
- [F5]30,250 SARs were exercisable on 8/8/09, 30,250 SARS were exercisable on 8/8/10, 30,250 SARs were exercisable on 8/8/11, and 30,250 SARs were exercisable on 8/8/12.
- [F6]30,250 SARs expire on 8/8/13, 30,250 SARS expire on 8/8/14, 30,250 SARs expire on 8/8/15, and 30,250 SARs expire on 8/8/16.
- [F7]The SARs, of which 90,750 were vested and 30,250 were unvested, were converted in the Merger Agreement into the right to receive a cash payment equal to $6.24 per share (representing the difference between the base price of the SAR and the merger consideration of $14.30).
- [F8]20,750 SARs were exercisable on 5/29/11, 20,750 SARS were exercisable on 5/29/12, and 20,750 SARs were exercisable on 5/29/13.
- [F9]20,750 SARs expire on 5/29/15, 20,750 SARS expire on 5/29/16, and 20,750 SARs expire on 5/29/17.